Literature DB >> 24622886

Expression of RUNX3 and β-catenin in the carcinogenesis of sporadic colorectal tubular adenoma.

Linna Wang1, Dan Li, Yang Liu, Yuan Wang, Jinfeng Cui, Airong Cui, Wenxin Wu.   

Abstract

The aim of this study is to investigate the possible roles of runt-related transcription factor 3 (RUNX3) and β-catenin in the carcinogenesis of sporadic colorectal tubular adenomas. The expression of the RUNX3 and β-catenin proteins was evaluated by immunohistochemistry in 23 normal colorectal mucosa (NCM), 81 sporadic colorectal tubular adenomas with different dysplasias (SCTA-D) (mild n=33, moderate n=23, and severe n=25 dysplasia), and 48 sporadic colorectal tubular adenomas with cancerous changes (SCTA-Ca). RUNX3 methylation was assessed by methylation-specific polymerase chain reaction (MSP), combined with laser capture microdissection (LCM), in 17 NCM, 41 SCTA-D (mild n=15, moderate n=12, and severe n=14 dysplasia), and 17 SCTA-Ca tissues. Compared to NCM (82.6 %), RUNX3 in SCTA-D (54.3 %) and SCTA-Ca (27.1 %) was significantly downregulated (P<0.05). In NCM, SCTA-D, and SCTA-Ca, the incidence of positive expression for β-catenin was 13.0, 60.5, and 79.2 %, respectively. A statistically significant difference was observed (P<0.05). RUNX3 levels were markedly higher in adenoma with mild dysplasia (75.8 %) and moderate dysplasia (60.9 %) than in adenoma with severe dysplasia (20.0 %) (both with P<0.05). Likewise, the expression of β-catenin in severe dysplasia adenoma was 84.0 %, which was significantly higher than that in mild dysplasia adenoma (39.4 %). An inverse correlation was found between the protein expression of RUNX3 and β-catenin in SCTA-D and SCTA-Ca (P<0.05). MSP results showed that RUNX3 methylation in NCM, SCTA-D, and SCTA-Ca was 5.9, 17.1, and 41.2 %, respectively, with a statistically significant difference between NCM and SCTA-Ca (P<0.05). However, no significant difference of RUNX3 methylation was observed among different dysplasia groups. RUNX3 and β-catenin play important roles in the carcinogenesis of sporadic colorectal tubular adenomas. In addition, hypermethylation of RUNX3 can downregulate its expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24622886     DOI: 10.1007/s13277-014-1800-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.

Authors:  K Maruyama; A Ochiai; S Akimoto; S Nakamura; S Baba; Y Moriya; S Hirohashi
Journal:  Oncology       Date:  2000-11       Impact factor: 2.935

2.  Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry.

Authors:  Chen Li; Yi Hong; Ye-Xiong Tan; Hu Zhou; Jian-Hua Ai; Su-Jun Li; Lei Zhang; Qi-Chang Xia; Jia-Rui Wu; Hong-Yang Wang; Rong Zeng
Journal:  Mol Cell Proteomics       Date:  2004-01-15       Impact factor: 5.911

3.  Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.

Authors:  Dominic Chih-Cheng Voon; Huajing Wang; Jason Kin Wai Koo; Tu Anh Pham Nguyen; Yit Teng Hor; Yeh-Shiu Chu; Kosei Ito; Hiroshi Fukamachi; Shing Leng Chan; Jean Paul Thiery; Yoshiaki Ito
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

Review 4.  The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer.

Authors:  Lopa Mishra; Kirti Shetty; Yi Tang; August Stuart; Stephen W Byers
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

5.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.

Authors:  Aram F Hezel; Vikram Deshpande; Stephanie M Zimmerman; Gianmarco Contino; Brinda Alagesan; Michael R O'Dell; Lee B Rivera; Jay Harper; Scott Lonning; Rolf A Brekken; Nabeel Bardeesy
Journal:  Cancer Res       Date:  2012-07-11       Impact factor: 12.701

7.  Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.

Authors:  Sze Chuen Cesar Wong; Elena Siu Fong Lo; King Chung Lee; John K C Chan; W L Wendy Hsiao
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

8.  Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells.

Authors:  Zhihai Peng; Huamei Tang; Xiaoliang Wang; Chongzhi Zhou; Junwei Fan; Liwei Wang; Zhiliang Jia; Qiang Li; Xiangdong Le; Daoyan Wei; Keping Xie
Journal:  Int J Oncol       Date:  2008-11       Impact factor: 5.650

Review 9.  Molecular pathology of RUNX3 in human carcinogenesis.

Authors:  Manish Mani Subramaniam; Jason Yongsheng Chan; Khay Guan Yeoh; Timothy Quek; Kosei Ito; Manuel Salto-Tellez
Journal:  Biochim Biophys Acta       Date:  2009-08-12

Review 10.  Growth regulation of gastric epithelial cells by Runx3.

Authors:  Hiroshi Fukamachi; Kosei Ito
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.